- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Multiple Myeloma in France
Total 551 results
-
Central Hospital, Nancy, FranceTerminated
-
University Hospital, CaenLaphalCompleted
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
Nantes University HospitalActive, not recruitingMultiple Myeloma at First RelapseFrance
-
Institut Paoli-CalmettesCompletedMultiple Myeloma and Plasma Cell NeoplasmFrance
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingChemotherapy | Newly Diagnosed Multiple Myeloma | Hematological PatientsFrance
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Cartesian TherapeuticsRecruiting
-
Nantes University HospitalTerminatedMultiple Myeloma in Older PatientsFrance
-
University Hospital, Clermont-FerrandLaboratoires TakedaUnknownMultiple Myeloma | Adult | Bortezomib RegimenFrance
-
Gustave Roussy, Cancer Campus, Grand ParisInnovative Therapies For Children with Cancer ConsortiumUnknownRelapsed or Refractory Pediatric TumorFrance, Ireland, Israel, Italy, Spain
-
Association for Training, Education, and Research...Active, not recruitingRefractory or Relapsed Lymphoid HaemopathyFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
AB ScienceRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Myelodysplastic Syndrome Acute Myeloid LeukemiaUnited States, Spain, France, Greece
-
Nantes University HospitalCompleted
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruiting
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada, United Kingdom, France, Belgium, Austria, Spain, Israel, Italy, Bulgaria, Czechia, Germany, Greece, Hungary, Netherlands, Poland, Romania, Russian Federation, Serbia, Sweden
-
Rennes University HospitalIntergroupe Francophone du MyelomeTerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaFrance
-
University Hospital, MontpellierHospices Civils de Lyon; Centre Hospitalier Universitaire de Nice; Centre Hospitalier... and other collaboratorsUnknown
-
Centre Hospitalier Universitaire de NīmesTerminated
-
Assistance Publique - Hôpitaux de ParisUnknownNewly Diagnosed Myeloma Patient Above 65 Years OldFrance
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Nantes University HospitalCompleted
-
University Hospital, ToulouseNot yet recruitingMultiple Myeloma | FrailtyFrance
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Nantes University HospitalCyceronNot yet recruiting
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
University of California, IrvineUnited States Department of DefenseActive, not recruitingAcute Myeloid Leukemia | Chronic Lymphocytic Leukemia | AML, Adult | CLL | CLL, Relapsed | CLL, RefractoryUnited States
-
National Cancer Institute (NCI)Childrens Oncology Group (COG); LLS PedAL LLCRecruitingDown Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...United States
-
Nantes University HospitalRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
SanofiCompleted
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Institut Paoli-CalmettesUnknownLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host DiseaseFrance
-
Institut CurieNational Cancer Institute, France; Fondation ARCTerminatedAcute Myeloid Leukemia, in Relapse | Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome | de Novo Acute Myeloid Leukemia at DiagnosticFrance
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Hoffmann-La RocheCompletedMultiple Myeloma, NeoplasmsUnited States, China, France, Spain, United Kingdom, Germany
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
SanofiTerminatedPlasma Cell MyelomaTaiwan, United States, Czechia, France, Greece, Spain
-
University Hospital, Strasbourg, FranceUnknown